Pharmacytimes: Condition Center: Asthma
Asthmaen-usSun, 22 Apr 2018 12:30:07 UTCSun, 22 Apr 2018 12:30:07 UTCSevere Weather and Asthma: A Tumultuous Thunderstorm
Weather can exacerbate asthma, and one specific trigger is thunderstorm activity.8:00 AM, Fri April 20, 2018Pediatric Asthma: Look for these Signs
Children may have to skip school, be admitted to the hospital, and occasionally, children die from asthma attacks. That's a clear call for better intervention on the part of healthcare providers.10:33 AM, Wed April 18, 2018Smart Inhaler Is About to Reach OTC Market
Smart Inhalers have been around for awhile, but have been consigned to use primarily in clinical trials. One company is bringing them to the OTC market.4:18 PM, Fri April 13, 2018Avoiding Errors With the Newer Inhalers
Several new devices for the administration of inhaled medications have been introduced.11:00 AM, Tue March 27, 2018A Breath of Fresh Air: Novel Treatments for Asthma
Novel therapies such as monoclonal antibodies and phenotype-guided treatments are available and clinicians are using them to help patients with severe asthma.8:00 AM, Fri March 23, 2018Nitric Oxide: A Potential Marker for Adherence in Asthma?
Current treatment options for patients living with asthma include long acting beta-agonists and inhaled corticoid steroids (ICS). While these therapeutic options are effective in a majority of patients, approximately 10% will remain poorly controlled.8:00 AM, Wed March 21, 2018Pharmacist-Provided Spirometry: Reducing Barriers to Better Asthma Care
Asthma and chronic obstructive pulmonary disorder are chronic health conditions that need to be properly diagnosed to be managed effectively.9:39 AM, Wed March 14, 2018The Smart Inhaler Market: Getting Bigger with New Players
More smart inhalers are coming to the US market and pharmacists may see them soon.8:37 PM, Tue March 6, 2018Improving Pediatric Asthma Care: Key Questions, Tips for Providers
Personalized inpatient assessments prior to prescribing asthma therapy to pediatric patients can improve the accuracy and quality of care.9:57 AM, Tue March 6, 2018Understanding Asthma: Significant Research Contributions from 2017
An international team of respiratory disease specialists looked back at 2017 and assembled a review of the current approaches to asthma and chronic obstructive pulmonary disease.2:00 PM, Mon March 5, 2018FDA Accepts Dupilumab sBLA for Treatment of Asthma
Sanofi recently announced that the FDA has accepted the supplemental Biologics License Application (sBLA) of dupilumab (Dupixent) for the maintenance treatment of asthma. 10:00 AM, Mon March 5, 2018Breath-Actuated Aerosol for Asthma Maintenance Launches
QVAR RediHaler is now commercially available to patients by prescription in 40 mcg and 80 mcg strengths.6:55 AM, Sat February 17, 2018Telemedicine, School-Based Medication Therapy Can Improve Asthma Outcomes
Children with asthma who receive a combination of telemedicine support and school-based medication therapy may be less likely to need an asthma-related emergency room or hospital visit.11:37 AM, Mon January 15, 2018FDA Officials Find No Increased Risk of Serious Outcomes with LABAs Used with ICS
The results of all trials showed that the use of LABA with ICS does not significantly increase the risk of serious asthma outcomes compared to ICS alone.1:33 PM, Thu December 21, 2017Medication Management in Schools: Pharmacist Involvement Can Improve Outcomes
Between 10% and 20% of students in kindergarten through high school have chronic illness.8:00 AM, Tue December 5, 2017The Answer to Preventing Childhood Asthma: Found in Gut Microbes?
An infant’s sex-specific gut microbiome following maternal asthma during pregnancy may influence their risk of developing childhood asthma.3:05 PM, Wed November 29, 2017COPD: Delving Into Inhaler Adherence
Chronic obstructive pulmonary disease (COPD)—irreversible—requires long-term adherence to pharmacotherapies for best outcomes.12:05 PM, Wed November 22, 2017FDA OKs Treatment for Severe Eosinophilic Asthma
Officials with the FDA have approved benralizumab (Fasenra, AstraZeneca) for the add-on maintenance treatment of patients with severe eosinophilic asthma aged 12 years and older.8:00 AM, Wed November 15, 2017Ensuring Patient Access to Asthma Therapy: Perspectives for Pharmacists
4:56 PM, Tue November 7, 2017Fish and Fish Oil Equally Protective Against Childhood Asthma?
9:00 AM, Thu November 2, 2017